However, QUE can reduce ROS-mediated mitochondrial damage and inflammation by regulating the Nrf2/HO-1 and p38 MAPK/NF-Bp 65/IL-8 signaling pathways, thereby antagonizing cardiotoxicity induced by CIS (113). This evidence concerns the gene HMOX1 and in situ carcinoma.